Vique-Sánchez JL - Search Results

1

γ-Secretase Inhibitors Selected by Molecular Docking, to Develop a New Drug Against Alzheimer's Disease.

Trasviña-Arenas CH, Ayala Medina LA, Vique-Sánchez JL. Trasviña-Arenas CH, et al. Among authors: vique sanchez jl. Rep Biochem Mol Biol. 2023 Jul;12(2):340-349. doi: 10.61186/rbmb.12.2.340. Rep Biochem Mol Biol. 2023. PMID: 38317814 Free PMC article.

2

Potential Inhibitors of The OTUB1 Catalytic Site to Develop an Anti-Cancer Drug Using In-Silico Approaches.

Galindo-Hernández O, García-Salazar LA, García-González VG, Díaz-Molina R, Vique-Sánchez JL. Galindo-Hernández O, et al. Among authors: vique sanchez jl. Rep Biochem Mol Biol. 2023 Jan;11(4):684-693. doi: 10.52547/rbmb.11.4.684. Rep Biochem Mol Biol. 2023. PMID: 37131907 Free PMC article.

3

AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells.

Galindo-Hernández O, Vique-Sánchez JL. Galindo-Hernández O, et al. Among authors: vique sanchez jl. Acta Pharm. 2022 Apr 13;72(3):329-343. doi: 10.2478/acph-2022-0024. Print 2022 Sep 1. Acta Pharm. 2022. PMID: 36651539 Free article.

4

Synergistic effect of compounds directed to triosephosphate isomerase, a combination to develop drug against trichomoniasis.

Benítez-Cardoza CG, Brieba LG, Arroyo R, Rojo-Domínguez A, Vique-Sánchez JL. Benítez-Cardoza CG, et al. Among authors: vique sanchez jl. Arch Pharm (Weinheim). 2022 Jun;355(6):e2200046. doi: 10.1002/ardp.202200046. Epub 2022 Mar 25. Arch Pharm (Weinheim). 2022. PMID: 35332589

5

Triosephosphate isomerase as a therapeutic target against trichomoniasis.

Benítez-Cardoza CG, Brieba LG, Arroyo R, Rojo-Domínguez A, Vique-Sánchez JL. Benítez-Cardoza CG, et al. Among authors: vique sanchez jl. Mol Biochem Parasitol. 2021 Nov;246:111413. doi: 10.1016/j.molbiopara.2021.111413. Epub 2021 Sep 16. Mol Biochem Parasitol. 2021. PMID: 34537286

6

Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2.

Benítez-Cardoza CG, Vique-Sánchez JL. Benítez-Cardoza CG, et al. Among authors: vique sanchez jl. Comput Biol Med. 2021 Sep;136:104719. doi: 10.1016/j.compbiomed.2021.104719. Epub 2021 Jul 31. Comput Biol Med. 2021. PMID: 34358993 Free PMC article.

7

Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking.

Vique-Sánchez JL. Vique-Sánchez JL. Bioorg Med Chem. 2021 Mar 1;33:116040. doi: 10.1016/j.bmc.2021.116040. Epub 2021 Jan 23. Bioorg Med Chem. 2021. PMID: 33515918 Free PMC article.

8

Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors.

Palos I, Moo-Puc R, Vique-Sánchez JL, Benítez-Cardoza CG, Monge A, Villalobos-Rocha JC, Paz-Gonzalez AD, Rivera G. Palos I, et al. Among authors: vique sanchez jl. Acta Pharm. 2020 Dec 31;71(3):485-495. doi: 10.2478/acph-2021-0032. Print 2021 Sep 1. Acta Pharm. 2020. PMID: 36654088 Free article.

9

Amoebicidal effect of 5,5'-[(4-nitrophenyl)methylene]bis-6-hydroxy-2-mercapto-3-methyl-4(3H)-pyrimidinone), a new drug against Entamoeba histolytica.

Vique-Sánchez JL, Jiménez-Pineda A, Benítez-Cardoza CG. Vique-Sánchez JL, et al. Arch Pharm (Weinheim). 2021 Feb;354(2):e2000263. doi: 10.1002/ardp.202000263. Epub 2020 Oct 5. Arch Pharm (Weinheim). 2021. PMID: 33017058

10

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug.

Benítez-Cardoza CG, Vique-Sánchez JL. Benítez-Cardoza CG, et al. Among authors: vique sanchez jl. Life Sci. 2020 Sep 1;256:117970. doi: 10.1016/j.lfs.2020.117970. Epub 2020 Jun 15. Life Sci. 2020. PMID: 32553928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page